Using lifetime risk estimates to recommend magnetic resonance imaging screening for breast cancer survivors

Journal of Clinical Oncology

Volumn 28, Issue 27, 2010, Pages 4108-4110

  Punglia, Rinaa S ^a   Hassett, Michael J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

BREAST CANCER; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CANCER SURVIVOR; GENE MUTATION; HETEROZYGOTE; HUMAN; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MASTECTOMY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; ARTICLE; BREAST TUMOR; CANCER STAGING; FEMALE; MASS SCREENING; METHODOLOGY; MORTALITY; PRACTICE GUIDELINE; PREDICTION AND FORECASTING; RISK FACTOR; STATISTICAL MODEL; STATISTICS; SURVIVOR; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

BREAST NEOPLASMS; FEMALE; GUIDELINE ADHERENCE; HUMANS; MAGNETIC RESONANCE IMAGING; MASS SCREENING; MODELS, STATISTICAL; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77957948610     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.30.0350     Document Type: Note

References (26)

1. De Angelis R, Tavilla A, Verdecchia A, et al: Breast cancer survivors in the United States: Geographic variability and time trends, 2005-2015. Cancer 115:1954-1966, 2009
2. Sprague BL, Trentham-Dietz A: Prevalence of breast carcinoma in situ in the United States. JAMA 302:846-848, 2009
3. Bernstein JL, Lapinski RH, Thakore SS, et al: The descriptive epidemiology of second primary breast cancer. Epidemiology 14:552-558, 2003 (Pubitemid 40417036)
4. Grunfeld E, Noorani H, McGahan L, et al: Surveillance mammography after treatment of primary breast cancer: A systematic review. Breast 11:228-235, 2002 (Pubitemid 34830704)
5. Lash TL, Fox MP, Buist DS, et al: Mammography surveillance and mortality in older breast cancer survivors. J Clin Oncol 25:3001-3006, 2007 (Pubitemid 47218045)
6. Nystrom L, Andersson I, Bjurstam N, et al: Long-term effects of mammography screening: Updated overview of the Swedish randomised trials. Lancet 359:909-919, 2002 (Pubitemid 34246378)
7. Berry DA, Cronin KA, Plevritis SK, et al: Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353:1784-1792, 2005 (Pubitemid 41549890)
8. Gøtzsche PC, Nielsen M: Screening for breast cancer with mammography. Cochrane Database Syst Rev 4:CD001877, 2009
9. Carlson RW, Allred DC, Anderson BO, et al: NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 7:122-192, 2009
10. Smith TJ, Davidson NE, Schapira DV, et al: American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 17:1080-1082, 1999
11. Keating NL, Landrum MB, Guadagnoli E, et al: Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol 24:85-94, 2006 (Pubitemid 46630498)
12. Schapira MM, McAuliffe TL, Nattinger AB: Underutilization of mammography in older breast cancer survivors. Med Care 38:281-289, 2000
13. Warner E, Messersmith H, Causer P, et al: Systematic review: Using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 148:671-679, 2008 (Pubitemid 351669112)
14. Veronesi U, Cascinelli N, Mariani L, et al: Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227-1232, 2002 (Pubitemid 35176241)
15. Gao X, Fisher SG, Emami B: Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: A population-based study. Int J Radiat Oncol Biol Phys 56:1038-1045, 2003 (Pubitemid 36794035)
16. Chen Y, Semenciw R, Kliewer E, et al: Incidence of second primary breast cancer among women with a first primary in Manitoba. Canada Breast Cancer Res Treat 67:35-40, 2001 (Pubitemid 32703386)
17. Fowble B, Hanlon A, Freedman G, et al: Second cancers after conservative surgery and radiation for stages I-II breast cancer: Identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys 51:679-690, 2001
18. Smith TE, Lee D, Turner BC, et al: True recurrence vs. new primary ipsilateral breast tumor relapse: An analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 48:1281-1289, 2000
19. Vaittinen P, Hemminki K: Risk factors and age-incidence relationships for contralateral breast cancer. Int J Cancer 88:998-1002, 2000
20. Obedian E, Fischer DB, Haffty BG: Second malignancies after treatment of early-stage breast cancer: Lumpectomy and radiation therapy versus mastectomy. J Clin Oncol 18:2406-2412, 2000 (Pubitemid 30415827)
21. Tamoxifen for early breast cancer: An overview of the randomised trials: Early Breast Cancer Trialists' Collaborative Group. Lancet 351:1451-1467, 1998
22. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
23. Clarke M, Coates AS, Darby SC, et al: Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: Patient-level meta-analysis of randomised trials. Lancet 371:29-40, 2008
24. Arias E: United States life tables, 2004. Natl Vital Stat Rep 56:1-39, 2007
25. Moore SG, Shenoy PJ, Fanucchi L, et al: Cost-effectiveness of MRI compared to mammography for breast cancer screening in a high risk population. BMC Health Serv Res 9:9, 2009
26. Taneja C, Edelsberg J, Weycker D, et al: Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women. J Am Coll Radiol 6:171-179, 2009